In this issue of Blood, Stepensky et al identify mutations of VPS45 as a new cause of congenital neutropenia and primary myelofibrosis.1 Severe congenital neutropenia (SCN)is characterized by severe isolated neutropenia from birth, recurring bacterial infections, and a marked propensity to develop a myelodysplastic syndrome or acute myeloid leukemia. SCN is a genetically heterogeneous disorder (see figure). Mutations of ELANE encoding neutrophil elastase (NE) account for;60 % of cases (all in autosomal dominant or sporadic SCN). Mutations of HAX1, G6PC3, GFI1, G6PT1, WAS, and CSF3R collectively account for approximately 10 % to 20 % of cases of SCN. Thus, the genetic basis for approximatel
VPS45-associated severe congenital neutropenia (SCN) is a rare disorder characterized by life-threat...
Severe congenital neutropenia (SCN) is a rare disease that involves a heterogeneous group of heredit...
Thesis (Ph.D.)--University of Washington, 2019Preleukemic diseases are highly informed by genetic pr...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73793/1/j.1365-2141.2007.06897.x.pd
BACKGROUND: The molecular cause of severe congenital neutropenia (SCN) is unknown in 30% to 50% of p...
Background: The molecular cause of severe congenital neutropenia (SCN) is unknown in 30% to 50% of p...
Congenital neutropenia and cyclic neu-tropenia are disorders of neutrophil pro-duction predisposing ...
Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemi...
Our understanding of the pathogenesis of congenital and acquired neutropenia is rapidly evolving. Ne...
Severe congenital neutropenia (SCN), Kostmann syndrome is a heterogenous disorder of myelopoiesis ch...
Severe congenital neutropenia as well as primary myelofibrosis are rare in infancy. Elucidation of t...
Severe congenital neutropenia (SCN) is a rare primary immunodeficiency. Different genes are found to...
PURPOSE OF REVIEW: Myeloid diseases are often characterized by a disturbed regulation of myeloid cel...
Severe congenital neutropenia (SCN) is a rare blood disorder characterized by abnormally low levels ...
SummarySevere congenital neutropenia (SCN) is characterized by a deficiency of mature neutrophils, l...
VPS45-associated severe congenital neutropenia (SCN) is a rare disorder characterized by life-threat...
Severe congenital neutropenia (SCN) is a rare disease that involves a heterogeneous group of heredit...
Thesis (Ph.D.)--University of Washington, 2019Preleukemic diseases are highly informed by genetic pr...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73793/1/j.1365-2141.2007.06897.x.pd
BACKGROUND: The molecular cause of severe congenital neutropenia (SCN) is unknown in 30% to 50% of p...
Background: The molecular cause of severe congenital neutropenia (SCN) is unknown in 30% to 50% of p...
Congenital neutropenia and cyclic neu-tropenia are disorders of neutrophil pro-duction predisposing ...
Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemi...
Our understanding of the pathogenesis of congenital and acquired neutropenia is rapidly evolving. Ne...
Severe congenital neutropenia (SCN), Kostmann syndrome is a heterogenous disorder of myelopoiesis ch...
Severe congenital neutropenia as well as primary myelofibrosis are rare in infancy. Elucidation of t...
Severe congenital neutropenia (SCN) is a rare primary immunodeficiency. Different genes are found to...
PURPOSE OF REVIEW: Myeloid diseases are often characterized by a disturbed regulation of myeloid cel...
Severe congenital neutropenia (SCN) is a rare blood disorder characterized by abnormally low levels ...
SummarySevere congenital neutropenia (SCN) is characterized by a deficiency of mature neutrophils, l...
VPS45-associated severe congenital neutropenia (SCN) is a rare disorder characterized by life-threat...
Severe congenital neutropenia (SCN) is a rare disease that involves a heterogeneous group of heredit...
Thesis (Ph.D.)--University of Washington, 2019Preleukemic diseases are highly informed by genetic pr...